| Nanostructured glycan architecture is important in the inhibition of influenza A virus infection SJ Kwon, DH Na, JH Kwak, M Douaisi, F Zhang, EJ Park, JH Park, ... Nature nanotechnology 12 (1), 48-54, 2017 | 145 | 2017 |
| HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles M Douaisi, S Dussart, M Courcoul, G Bessou, R Vigne, E Decroly Biochemical and biophysical research communications 321 (3), 566-573, 2004 | 123 | 2004 |
| Light-activated nanotube–porphyrin conjugates as effective antiviral agents I Banerjee, MP Douaisi, D Mondal, RS Kane Nanotechnology 23 (10), 105101, 2012 | 83 | 2012 |
| CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus M Douaisi, RS Resop, M Nagasawa, J Craft, BD Jamieson, B Blom, ... The Journal of Immunology 198 (6), 2310-2319, 2017 | 46 | 2017 |
| The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin S Dussart, M Courcoul, G Bessou, M Douaisi, Y Duverger, R Vigne, ... Biochemical and biophysical research communications 315 (1), 66-72, 2004 | 41 | 2004 |
| The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles M Douaisi, S Dussart, M Courcoul, G Bessou, EC Lerner, E Decroly, ... Biochemical and biophysical research communications 329 (3), 917-924, 2005 | 35 | 2005 |
| Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery RS Resop, M Douaisi, J Craft, LCM Jachimowski, B Blom, ... Journal of Allergy and Clinical Immunology 138 (2), 551-557. e8, 2016 | 28 | 2016 |
| Perhydrolase-nanotube paint composites with sporicidal and antiviral activity N Grover, MP Douaisi, IV Borkar, L Lee, CZ Dinu, RS Kane, JS Dordick Applied microbiology and biotechnology 97, 8813-8821, 2013 | 27 | 2013 |
| APOBEC3G ubiquitination by Nedd4-1 favors its packaging into HIV-1 particles S Dussart, M Douaisi, M Courcoul, G Bessou, R Vigne, E Decroly Journal of molecular biology 345 (3), 547-558, 2005 | 24 | 2005 |
| Design of Monodisperse and Well‐Defined Polypeptide‐Based Polyvalent Inhibitors of Anthrax Toxin S Patke, M Boggara, R Maheshwari, SK Srivastava, M Arha, M Douaisi, ... Angewandte Chemie International Edition 53 (31), 8037-8040, 2014 | 22 | 2014 |
| A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion N Legrand, GJ van der Velden, RHT Fang, M Douaisi, K Weijer, AT Das, ... Journal of general virology 93 (9), 2017-2027, 2012 | 10 | 2012 |
| Preparation of low molecular weight heparin from a remodeled bovine intestinal heparin SN Baytas, SS Varghese, W Jin, Y Yu, P He, M Douaisi, F Zhang, ... Journal of medicinal chemistry 64 (4), 2242-2253, 2021 | 7 | 2021 |
| Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency JT Martin, M Douaisi, A Arsiwala, M Arha, RS Kane International Journal of Nanomedicine, 5249-5253, 2018 | 6 | 2018 |
| Isobutanol production by combined in vivo and in vitro metabolic engineering M Gupta, M Wong, K Jawed, K Gedeon, H Barrett, M Bassalo, C Morrison, ... Metabolic Engineering Communications 15, e00210, 2022 | 4 | 2022 |
| La protéine Vif du VIH1 neutralise les mécanismes innés de défense antirétrovirale liés à APOBEC3G [revue] M Douaisi, S Dussart, Y Duverger, M Courcoul, G Bessou, R Vigne, ... Virologie 8 (2), 87-94, 2004 | 2 | 2004 |
| Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin M Douaisi, EE Paskaleva, L Fu, N Grover, CL McManaman, S Varghese, ... Proceedings of the National Academy of Sciences 121 (14), e2315586121, 2024 | | 2024 |
| Biosynthetic heparin M Douaisi, N Grover, P Datta, E Paskaleva, L Lin, P Brodfuehrer, ... US Patent App. 18/099,749, 2023 | | 2023 |
| Biosynthetic heparin M Douaisi, N Grover, P Datta, E Paskaleva, L Lin, P Brodfuehrer, ... US Patent 11,591,628, 2023 | | 2023 |
| Biosynthetic Heparin DOUAISI, Marc, GROVER, Navdeep, DATTA, Payel, PASKALEVA, Elena, ... WO Patent WO2018048973A1, 2018 | | 2018 |
| A role for CD31 (PECAM-1) during T cell differentiation in the human thymus (HEM2P. 239) M Douaisi, R Resop, B Jamieson, C Uittenbogaart The Journal of Immunology 194 (1_Supplement), 51.9-51.9, 2015 | | 2015 |
Sanket PatkeSanofiVerified email at sanofi.com
